Apellis Pharmaceuticals
APLS
$52.77
Share price
-0.02%
Change (1 day)
41.78%
Change (1 year)
P/S ratio for Apellis Pharmaceuticals (APLS)
P/S ratio as of January 2023 (TTM): 51.1
According to Apellis Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 51.1363. At the end of 2022 the company had a P/S ratio of 66.4.
P/S ratio history for Apellis Pharmaceuticals from 2017 to 2022
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2022 | 66.4 | -4.02% |
| 2021 | 69.2 | 300.1% |
| 2020 | 17.3 | |
| 2019 | N/A | |
| 2018 | N/A | |
| 2017 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | -100.00% | 🇺🇸 USA |